Brain chemical could predict who benefits from stimulation therapy

NCT ID NCT07196423

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 26 times

Summary

This study looks at how a brain chemical called glutamate may be linked to memory and attention problems in people who have recently had psychosis. Researchers will use brain scans and a gentle electrical stimulation technique to see if glutamate levels can predict who will benefit from this treatment. The goal is to better understand brain chemistry and find ways to personalize care for individuals with psychosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Nottingham

    Nottingham, Nottinghamshire, NG7 2RD, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.